Bio-Path Holdings, Inc.
BPTH · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $7 | $12 | $9 | $6 |
| G&A Expenses | $5 | $4 | $5 | $5 |
| SG&A Expenses | $5 | $4 | $5 | $5 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $0 | $0 | $0 |
| Operating Expenses | $12 | $16 | $14 | $10 |
| Operating Income | -$12 | -$16 | -$14 | -$10 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $2 | -$0 | $0 | $0 |
| Pre-Tax Income | -$10 | -$16 | -$14 | -$10 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$10 | -$16 | -$14 | -$10 |
| % Margin | – | – | – | – |
| EPS | -4.12 | -33.64 | -38.03 | -31.04 |
| % Growth | 87.8% | 11.5% | -22.5% | – |
| EPS Diluted | -4.12 | -33.64 | -38.03 | -31.04 |
| Weighted Avg Shares Out | 2 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 2 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$10 | -$16 | -$14 | -$10 |
| % Margin | – | – | – | – |